We are COMPASS Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Our first clinical development programme is researching investigational COMP360 psilocybin treatment for patients with treatment-resistant depression. We want to...See more
Headquarter United Kingdom of Great Britain and Northern Ireland |
Countries of operation United Kingdom of Great Britain and Northern Ireland, Australia, New Zealand |
Year founded 2016 (8 years) |
Funding status Publicly listed on stock exchange |
Company type MNC / Large Enterprise |
Paralegal - Risk, Compliance & IP
Clinical Research Scientist
Shareholder
Job title | Name | Email | Country based in | Job Function | Seniority | |
---|---|---|---|---|---|---|
Paralegal - Risk, Compliance & IP | hidden.item | hidden.item | hidden.item | |||
Clinical Research Scientist | hidden.item | hidden.item | hidden.item | |||
Shareholder | - | hidden.item | hidden.item | hidden.item |